Latest News about ABBV
Recent news which mentions ABBV
AbbVie's Cancer Drug Venetoclax Falls Short In Phase 3 Combination Trial For Myelodysplastic Syndromes
Today 10:43 EDT
From Benzinga
FDA Expands AbbVie's Mavyret Label To Include Pediatric Patients With Hepatitis C Infection
June 11, 2025
From Benzinga
From Benzinga
From Motley Fool
From Motley Fool
AnaptysBio's Arthritis Drug Matches Top Therapies In Phase 2 Trial, Analyst Sees Turning Point
June 04, 2025
From Benzinga
9 Health Care Stocks Whale Activity In Today's Session
June 04, 2025
From Benzinga
3 Cheap Dividend Growth Stocks to Buy Right Now
June 04, 2025
From Motley Fool
4 Forever Dividend Stocks to Buy
June 03, 2025
From Motley Fool
From Benzinga
From TalkMarkets
From Benzinga
From Benzinga
From Benzinga
U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result
May 24, 2025
From Motley Fool
Elon Musk Commits to Tesla. Is That a Good Thing?
May 23, 2025
From Motley Fool
2 Incredible Dividend Growth Stocks to Buy Now
May 21, 2025
From Motley Fool
From Benzinga
From Motley Fool
From Motley Fool
From Benzinga
AbbVie Stock In 2025: Dividend Powerhouse Or Dead Weight? What Smart Investors Need To Know Now
May 15, 2025
Tickers
ABBV
From TalkMarkets
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
